TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number and proportion of good-quality ECG recordings taken by parents/caregivers with a physician present
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and proportion of good-quality ECG recordings taken by parents/caregivers with a physician absent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and proportion of good-quality ECG recordings taken by parents/caregivers at home
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Patient Assessment of Chronic Illness Care (PACIC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: complete lymph node clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: improvement in cardiac remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Financial well-being
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Food insecurity
Endpoint domain: Life impact
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Implant survival/success
Endpoint domain: Mortality/survival
Primary endpoint: Change in the Pittsburgh Sleep Quality Index (PSQI) total score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in the Insomnia Severity Index (ISI) total score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in actigraphic total sleep time (TST)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Proportion of participants with peripheral sensory neuropathy (NP) of Grade 2 or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of hospital admission for >24 hours
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidence rate of newly diagnosed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Absolute number of Asthma or COPD or ACO patients (per ICD-10) annually
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of Asthma or COPD or ACO patients (per ICD-10) annually
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Grandparents' psychological wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Grandparents' quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Grandparents' involvement and burnout
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Area under the concentration versus time curve of plasma glucagon (AUC60-120min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Eating Disorder Examination Questionnaire (EDE-Q6)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Eating Attitude Test (EAT-26)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Impairment Assessment Questionnaire (CIA 3.0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients with high financial toxicity
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: VAS evaluation results for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of CAR-T cell preparations
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended dose and infusion regimen of CAR-T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sum of finger-pressure readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sum of tip-pressure readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival of implants at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Joint position sense change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps muscle strength change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Y balance test change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with abnormal laboratory examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in ECOG score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: IL-1β changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CRP changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Post-PCI Fractional Flow Reserve (FFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Absolute refractive predictability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in BMI at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Food Insecurity Status at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Diet Quality at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in patient care during MRI-guided procedures
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Percentage of participants achieving a proptosis response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Adjustment Scale- Self Report
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Addiction Severity Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of HV-101
Endpoint domain: Adverse events/effects
Primary endpoint: Computerized Dynamic Visual Acuity (cDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective memory scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Absence of pathological postoperative fat necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area under the curve for receiver operating characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endothelial cell Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Abdominal assessment scale for Preterm infants score (ECAP score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICD candidacy prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Paternal Infant Attachment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Non-ocular Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of gynaecological speculum examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Exposure-related Change From Baseline of cGMP in CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum Measured Concentration (Cmax) Ratio of BI 474121 in CSF Compared to Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Turning angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Turning step
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants developing diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentration of Zonulin-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Relationship of glucagon with hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Start and Stop Date of Guselkumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Start and Stop Date of Interleukin-17 Inhibitor (IL-17i)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SUV mean measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete recovery from COVID-19 with resolution of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Admission to a hospital for further advanced treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance with the assigned hand hygiene technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-traumatic growth (PTG)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Joint rank scores (CAFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined Assessment of Functional and Survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Most recent HIV test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Ocular and Systemic Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Abnormal Findings in Clinical Laboratory Assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Abnormal Findings in Retinal imaging and Eye Examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Neuro-pharmacokinetic profile of posaconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving an Investigator's Global Assessment (IGA) Score of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Psoriasis Area and Severity Index (PASI) 90 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with treatment-related adverse events (liver function)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment-related adverse events (blood counts)
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of negative symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of NEU-SFL
Endpoint domain: Mortality/survival
Primary endpoint: Standard Deviation of Activation Times (SDAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left Ventricular Activation Times (LVAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: QRS Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in cerebral dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Virological response to BLV therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of the inferior alveolar nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women experiencing intimate partner violence during pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: Hospitalization for heart failure
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of logins to the assigned application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Physical activity timing adherence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RPVO (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Segmental visual score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalized Anxiety Disorder remission
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wearing Tolerance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Delta CK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diet iodine intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: urinary iodine excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hematology Hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety and tolerability of ChAdOx1 biEBOV
Endpoint domain: Adverse events/effects
Primary endpoint: COVID-19 Vaccination Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite endpoint event rate at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in fibrosis by at least 1 stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: NASH resolution without worsening of fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: PSA Response Rate
Endpoint domain: Physiological/clinical
Primary endpoint: Number of registrations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Number of Participants With Moderate or More Severe Fever, Chills, Myalgia, or Arthralgia
Endpoint domain: Adverse events/effects
Primary endpoint: Need for surfactant administration or positive pressure ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Z-score of coronary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Degree of postoperative bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants Treated with Icatibant in the Homecare Setting who Were Receiving Prophylaxis Treatment at Index
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Treated with Icatibant in the Homecare Setting in Each Prophylactic Treatment Type
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of life (QLQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ventricular drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Ventricular size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Time to carry out non-pharmacological therapies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of professional caregivers involved in non-pharmacological therapies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fatigue Numeric Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change of blood lipid (Triglyceride, total cholesterol, HDL-C, LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of ALT and AST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of cardiovascular endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first occurrence of CLAD, lung retransplant, or death
Endpoint domain: Mortality/survival
Primary endpoint: State- Trait Anxiety Inventory 6 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cmax of EQ143
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of EQ143
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of EQ143
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients Medication Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in SARS-CoV-2 viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in EORTC QLQ-C30 Quality of Life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Gait parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ENERGY EXPENDITURE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Out of clinic 24 hour ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Out of clinic awake blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Out of clinic asleep blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Emotional Perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Quality of Life from baseline
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Decisions to Stop Surveillance Imaging
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Decisions to Continue Surveillance Imaging
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fecal sIgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Chronic Cough Impact Questionnaire (CCIQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Body composition assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individual physical function assessments
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Retroglossal pharyngeal cross sectional areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eczema Area and Severity Index (EASI) 75 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Return to unrestricted physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Effectiveness of the physical rehabilitation program for lower limb strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of the physical rehabilitation program for upper limb strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical behavioral evolution of quality of life perception
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 90-day Functional Outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The visual analog scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Quantification of anti-SARS-CoV-2 receptor binding domain specific IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: complete mucosal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polyp Closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of participants achieving clinically significant improvement in asthma-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change in GEA (Global Evaluation Acne) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Adult Female Acne Scoring Tool (AFAST) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in acne count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in the seborrhea evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma EPA+DHA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Fear and Avoidance Ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: waist to hip ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Deep vein thrombosis
Endpoint domain: Mortality/survival
Primary endpoint: Pulmonary embolism
Endpoint domain: Mortality/survival
Primary endpoint: reduction rate of paradoxical upgrading reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Change in muscle spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Overall pain relief
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of changes in antimicrobial regimen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline in monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel frequency movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: VDR expression in the endometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PYY
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: OMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IgE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Blood parathyroid hormone (PTH) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes